How to Start GLP-1 for Weight Loss: Step-by-Step Guide

Your GLP-1 Start Plan at a Glance

What Is GLP-1 and Why Does It Work So Well?

GLP-1 stands for glucagon-like peptide-1. It’s a hormone your gut releases after you eat, and it tells your brain you’re full, slows your digestion, and helps regulate blood sugar. GLP-1 medications — technically called GLP-1 receptor agonists — work by mimicking that natural hormone, but at levels far higher than your body produces on its own.

The result: your appetite quiets down. The constant mental chatter about food (what doctors call “food noise”) fades. You feel satisfied with smaller portions. And because you’re eating less without white-knuckling it, you lose weight — steadily, and for many people, significantly.

This isn’t a stimulant. It’s not an appetite suppressant in the old-school sense. It works with your biology, not against it.

The clinical data is striking

• In the landmark STEP 1 trial, people on semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks — vs. 2.4% with placebo (NEJM, 2021).
• The newer STEP UP trial showed semaglutide at 7.2 mg achieved 20.7% average weight loss over 72 weeks, with one-third of participants losing over 25% (Novo Nordisk, 2025).
• Tirzepatide (Zepbound) showed up to 22.5% weight loss at the highest dose in the SURMOUNT-1 trial (NEJM, 2022).
• The SELECT trial found semaglutide reduced the risk of heart attack, stroke, and cardiovascular death by 20% in people with obesity and heart disease (NEJM, 2023).
• Real-world data backs this up: patients using semaglutide 2.4 mg lost an average of 17.6% at 12 months (PMC, 2024).

The medications you’ll hear about

• Semaglutide — Wegovy (FDA-approved for weight loss), Ozempic (approved for diabetes, same drug), and the Wegovy tablet (oral semaglutide 25 mg, FDA-approved December 2025, launched January 2026). Weekly injection or daily tablet.
• Tirzepatide — Zepbound (weight loss), Mounjaro (diabetes). Weekly injection. Works on both GLP-1 and GIP receptors (dual action).

Both are legitimate, well-studied medications. We’ll help you understand which one makes more sense for you below.

If you’re looking for ways to increase GLP-1 naturally (through food, fiber, protein timing, etc.), that’s a different goal. This page focuses on GLP-1 medication for weight loss.

Step 1: Do You Qualify for GLP-1 Medication?

You probably do. Most adults with significant excess weight qualify.

The standard eligibility criteria (per FDA labeling)

• BMI ≥30 (obesity) — no additional conditions required, OR
• BMI ≥27 with at least one weight-related health condition. Per FDA labeling, examples include hypertension, dyslipidemia, and type 2 diabetes. Your clinician or insurer may also consider conditions like sleep apnea, PCOS, or pre-diabetes.

Quick BMI reference

If you’re close to these numbers and have any of the conditions listed above, you likely qualify. Your provider makes the final determination — but the bar is lower than most people think.

Who Should NOT Start GLP-1 (Red Flags)

Per FDA prescribing information (Wegovy PI, Zepbound PI):

Step 2: Which GLP-1 Should You Start? (Semaglutide vs. Tirzepatide)

Short answer: both work. Your provider will recommend one based on your health profile. Here’s what separates them.

Pick this if you’re…

• Needle-averse: Ask your provider about oral semaglutide (Wegovy tablet). It’s the first GLP-1 tablet approved for weight loss and showed 13.6% average weight loss at 64 weeks in the OASIS 4 trial. Take it daily on an empty stomach with no more than 4 oz of water, then wait 30 minutes before eating, drinking, or taking other medications.
• Focused on maximum weight loss: Tirzepatide edges out semaglutide slightly in head-to-head comparisons at the highest doses. But the difference matters less than consistency and adherence.
• Budget-conscious and going cash-pay: Compounded semaglutide is more widely available and typically cheaper through telehealth programs. Many providers (including MEDVi) offer both semaglutide and tirzepatide.
• Already taking diabetes medication: Tell your provider. They need to coordinate doses — particularly if you’re on insulin or sulfonylureas.

What about Ozempic, Mounjaro, Rybelsus, and Saxenda? Ozempic and Mounjaro are FDA-approved for type 2 diabetes (not weight loss), though they contain the same active ingredients as Wegovy and Zepbound. Doctors sometimes prescribe them off-label for weight. Rybelsus is an older oral semaglutide (lower dose, smaller effect). Saxenda (liraglutide) is a daily injection with more modest weight loss. For most people starting in 2026, Wegovy/Zepbound (or their compounded equivalents) are the primary options. Read our semaglutide vs tirzepatide comparison for a detailed breakdown.

Step 3: How to Choose Your Provider Path (Doctor vs. Telehealth vs. Insurance)

This is where most people stall. There are three realistic paths to get GLP-1 prescribed. Each has tradeoffs in speed, cost, and safety.

One path you should NEVER take

Do not buy GLP-1 from sites that don’t require a prescription, sell “research peptides,” or offer “compounded semaglutide” without a legitimate medical evaluation. The FDA has issued multiple warnings about unapproved GLP-1 products associated with dosing errors, contamination, and hospitalizations. If a site doesn’t require your medical history and a licensed prescriber’s review, walk away.

If you’re choosing telehealth: what “good care” actually looks like

• A real medical screening (health history, medication list, not just “enter your credit card”)
• A named, licensed prescriber who reviews your case
• A named pharmacy partner (not “our proprietary blend”)
• Clear pricing — what does month 1 cost? What do refills cost? Are consults extra?
• Cancellation policy transparency — can you stop anytime?
• Follow-up support — can you message a provider about side effects?
• LegitScript certification — you can verify any provider’s website here

We evaluated dozens of telehealth GLP-1 providers against these criteria. For a fast, affordable start with strong support, MEDVi consistently scores highest on our evaluation — $179 first month (medication included), 24/7 provider access, LegitScript certified, and pharmacy partners you can actually verify (Belmar Pharma Solutions, Beluga Health). They’re available in 49 states and offer both injectable and oral tablet options.

MEDVi isn’t the only good option — Eden offers predictable flat pricing, and BreezeMeds serves all 50 states. But for most people who want a reliable, well-supported start without weeks of insurance runaround, MEDVi is where we’d point you. See our full provider comparison for the complete analysis.

Affiliate disclosure: We earn a commission if you sign up through our links. We recommend MEDVi because it meets our evaluation criteria — not because of the commission.

Compounded vs. brand-name: the distinction you need to understand

• Brand-name (Wegovy, Zepbound): FDA-approved products with standardized manufacturing. The clinical trial data is based on these. Gold standard for regulatory certainty.
• Compounded: Custom-prepared by licensed compounding pharmacies. The final product is NOT FDA-approved. The FDA has warned that some products marketed as “compounded semaglutide” may use different salt forms that are not the same active ingredient. More affordable — which is why most telehealth programs use them.

Our take: If you go compounded, the pharmacy and provider matter enormously. Ask your provider which pharmacy fulfills your prescription, and verify it’s a licensed 503A or 503B facility. Programs that name their pharmacy partners (and are LegitScript certified) are safer bets. Read our compounded semaglutide safety guide for the full analysis.

Step 4: How to Prepare Your Body Before Your First Dose

You don’t need to overhaul your life. But 5–7 days of simple prep makes your first weeks significantly easier — less nausea, less fatigue, less constipation. These aren’t random tips. They’re based on what obesity medicine dietitians and clinicians consistently recommend (Ohio State University, UCHealth).

The GLP-1 Readiness Checklist

Step 5: Starting Dose and Titration (Why “Low and Slow” Is Non-Negotiable)

Every GLP-1 medication starts at a dose too low to produce significant weight loss. That’s by design. The starting dose is about teaching your body to tolerate the medication so you can eventually reach the therapeutic dose without unbearable side effects.

Do not skip doses. Do not jump ahead. Do not let impatience convince you to escalate faster than your provider prescribes.

Semaglutide (Wegovy) Titration Schedule

Per the FDA-approved prescribing information:

Tirzepatide (Zepbound) Titration Schedule

Your provider may slow the schedule if side effects are significant — and that’s the right call. Faster escalation = more nausea = higher chance of quitting. Patience during titration is what separates people who succeed long-term from people who stop after month two.

What if you miss a dose?

What about “microdosing” GLP-1?

You’ll see this term online. It usually means staying on a very low dose long-term instead of titrating up. There’s no clinical evidence supporting this approach, and with compounded vials (vs. prefilled pens), the dosing-error risk is real. The FDA has specifically flagged dosing errors with compounded semaglutide. Only adjust doses under your provider’s direction.

Step 6: Your First GLP-1 Injection (It’s Easier Than You Think)

If the needle is what’s holding you back, here’s the truth: GLP-1 needles are tiny. They’re subcutaneous (just under the skin, into fat — not into a vein or muscle). Most people compare it to a quick pinch. After the second or third time, it becomes a 30-second routine.

General injection steps (for most prefilled pens)

1. Wash your hands.
2. Choose your injection site: abdomen (at least 2 inches from your belly button), outer thigh, or upper arm. Rotate sites each week.
3. Clean the area with an alcohol swab. Let it dry.
4. Prepare the pen per your device’s IFU (some require needle attachment and dose dialing; others are preset).
5. Pinch a fold of skin. Insert the needle subcutaneously per your IFU directions.
6. Inject the dose. Hold for the time specified in your IFU (typically 5–10 seconds).
7. Remove the needle. Don’t rub the site.
8. Dispose of the needle in a sharps container. Never reuse.

If you’re using a compounded vial + syringe

This requires more care. You’re drawing medication from a vial with an insulin syringe, and dosing errors are the biggest risk. Never guess on the amount. Your pharmacy should provide specific instructions for your concentration and prescribed dose. If anything is unclear — call them before injecting.

• Confirm the concentration (mg/mL) with your provider and pharmacy
• Use the correct syringe type (insulin syringes, typically)
• Clean the vial top with alcohol before each draw
• Store properly — refrigerate per instructions

Needle-free option

If injections are truly a dealbreaker, ask your provider about oral semaglutide (Wegovy tablets, FDA-approved December 2025). It’s a once-daily tablet swallowed whole on an empty stomach with no more than 4 oz of water — wait 30 minutes before eating, drinking, or taking other oral medications. In the OASIS 4 trial, it showed 13.6% mean weight loss at 64 weeks (NEJM, 2025). Read our oral vs injectable semaglutide comparison for more details.

What to Expect: Your First Week on GLP-1

Your first week is about adjustment, not dramatic results. Here’s what’s actually going to happen.

Day 1–2: Injection Day and After

You took the dose. Now what? You might feel nothing at all — many people don’t notice anything the first day. Or you might feel:

• Mild nausea (usually 4–8 hours after injection)
• A subtle sense of fullness, even without eating much
• Slight fatigue or a “foggy” feeling

Eat small, bland meals. Drink water. Don’t test the medication with a large dinner out. Keep it boring and easy.

Day 3–4: The Appetite Shift

This is when most people first notice the medication working. The food noise gets quieter. You look at a plate of food and feel satisfied with half of it. You forget to think about snacking.

Important: you still need to eat. Don’t skip meals because you’re not hungry. Eat for nutrition — especially protein. A protein shake is a good safety net on low-appetite days.

Day 5–7: Settling In

Side effects (if you had them) typically peak around day 2–3 and start improving by day 5. Constipation may show up around now — this is where your prep (hydration + fiber + walking) pays off.

Weight change in week 1 is mostly water and reduced food volume. Expect 1–3 lbs. Don’t obsess. Weekly weigh-ins are more useful than daily.

What to Expect: Your First 30 Days on GLP-1

Week 1–2: The Adjustment Phase

You’re on the lowest dose. This isn’t the “weight loss dose” — it’s the “get your body used to it” dose. Side effects are most likely during this window: nausea, constipation, maybe some fatigue or headache. Don’t be discouraged by slow weight loss.

Week 3–4: Building Momentum

Appetite suppression becomes more consistent. Behavioral changes emerge naturally — smaller portions feel normal, cravings weaken, snacking drops. Many people report 4–8 lbs lost by end of month 1 (varies widely by starting weight and individual biology).

Energy often improves as your body adapts. Some people describe a sense of calm around food they’ve never experienced before. That’s the “food noise” turning off.

At the 4-week mark, your provider will typically discuss the first dose increase. The titration continues — and with each step up, the appetite effects strengthen.

What real users say about their first month

GLP-1 Side Effects: What’s Normal, What’s Fixable, and When to Call Your Doctor

Let’s be direct: side effects are real. The most common ones are gastrointestinal, and they tend to show up during the first few weeks and during dose increases. For most people, they’re manageable and temporary. For a smaller number, they’re the reason they stop.

Common Side Effects and How to Handle Them

When to Call Your Provider Immediately

The Honest Numbers on Quitting

Here’s the uncomfortable stat: about half of people stop GLP-1 within the first year. The biggest reasons are side effects, cost, and insufficient follow-up support (SteadyMD, 2024).

The people who succeed long-term tend to have three things in common:

1. They started with a provider who offers real follow-up (not a one-and-done prescription).
2. They expected the first 2–4 weeks to be an adjustment period — not instant results.
3. They built the habits (protein, hydration, movement) that make the medication work best.

That’s exactly what this guide is designed to set you up for. For a deeper dive, see our complete guide to GLP-1 pros and cons.

What to Eat on GLP-1 (The Practical Diet Guide)

You don’t need a special diet plan. But what you eat matters more on GLP-1 — because you’re eating less, every bite carries more weight for nutrition, muscle preservation, and side-effect management.

The 3 Rules (Keep It Simple)

Foods That Work Well on GLP-1

• Lean proteins: chicken, fish, eggs, cottage cheese, Greek yogurt
• Non-starchy vegetables: broccoli, spinach, bell peppers, zucchini, asparagus
• Complex carbs (moderate): sweet potato, quinoa, brown rice, oats
• Healthy fats (small portions): avocado, olive oil, nuts, seeds
• Comfort foods for nausea days: ginger tea, bone broth, bananas, plain crackers, toast
• Protein shakes: your safety net when appetite is very low

Foods That Make Side Effects Worse (Especially Early On)

• Greasy and fried foods — the single biggest nausea trigger on GLP-1
• Large portions — your stomach is processing food more slowly
• Sugary drinks and processed sweets — empty calories when every calorie counts
• Alcohol — worsens nausea, adds empty calories, impairs blood sugar regulation
• Spicy food — can worsen reflux and nausea, particularly in the first 2–4 weeks

A Simple Eating Pattern That Works

Think of your plate in thirds: one-third protein, one-third vegetables, one-third complex carb or healthy fat. Eat 3 small meals and 1–2 protein-rich snacks. Eat slowly — put the fork down between bites. Stop when you’re satisfied, not stuffed. On days when you have zero appetite, at minimum have a protein shake and some fruit.

Exercise on GLP-1: What Actually Matters

Exercise isn’t optional. It’s what separates people who lose fat and keep muscle from people who lose both.

The Two Non-Negotiables

A Simple Starter Plan

• Weeks 1–2: 15–20 minute walks daily. Get the habit started while your body adjusts.
• Weeks 3–4: 30-minute walks + 2 bodyweight sessions per week (squats, push-ups, lunges, planks, resistance band rows).
• Month 2+: Build from there. Increase walking duration or intensity. Add weight to your resistance exercises.

How Much Does GLP-1 Actually Cost? (Real Numbers, No Spin)

Cost is one of the top reasons people either don’t start or stop early. Here’s the full picture.

The cost reality most people land on

If your insurance covers Wegovy or Zepbound with a low copay — that’s the cheapest path and uses FDA-approved products. Pursue it. If insurance denies you or you don’t have coverage, you now have two realistic options: brand-name self-pay programs from the manufacturers (NovoCare Pharmacy for Wegovy, Lilly’s program for Zepbound) or compounded telehealth programs. Read our complete GLP-1 cost guide for the full breakdown.

The insurance prior authorization playbook

1. Your provider submits a prior authorization request documenting your BMI, comorbidities, and prior weight loss attempts.
2. Insurance reviews (this takes days to weeks).
3. If approved: great, fill the prescription.
4. If denied: appeal. Include documentation of prior failed diet/exercise programs and a letter of medical necessity.
5. If the appeal fails: consider a manufacturer savings card, or switch to a cash-pay telehealth path.

Many people run the insurance process in parallel with telehealth — start cash-pay to avoid waiting, then switch to insurance if approval comes through.

How Long Does It Take to Lose Weight on GLP-1?

The honest answer: faster than any diet, but not overnight.

Clinical reference: Patients on semaglutide 2.4 mg lost an average of 6% by week 12, 12% by week 28, and 14.9% by week 68 in the STEP 1 trial. Real-world data shows 17.6% at 12 months with consistent use (PMC, 2024).

Plateaus Happen. Here’s What to Do.

• Check protein intake. Are you consistently hitting 80–100 grams per day?
• Check hydration. Dehydration slows everything.
• Add or increase strength training. Muscle burns more calories at rest.
• Look at sleep. Poor sleep tanks hormones that regulate hunger and metabolism.
• Talk to your provider. A dose adjustment may be appropriate.

For a deeper dive on plateaus, see our GLP-1 plateau guide with the 7-step fix plan.

What Happens If You Stop Taking GLP-1?

We’re not going to soft-pedal this: weight regain after stopping is common and well-documented. The STEP 4 trial found that participants who switched from semaglutide to placebo regained about two-thirds of their lost weight within a year (JAMA, 2021).

This isn’t a failure of willpower. Obesity is a chronic condition driven by hormonal and neurological signals. When you remove the medication correcting those signals, the signals return.

What this means practically

• GLP-1 is increasingly viewed as a long-term or ongoing medication, not a “course of treatment” you finish.
• Some people successfully transition to a lower maintenance dose after reaching their goal.
• The lifestyle habits you build while on GLP-1 are your insurance policy.

Read our complete guide on what happens when you stop GLP-1 for the full analysis.

Is GLP-1 Safe? What the Research Actually Shows

GLP-1 medications have been studied more rigorously than almost any weight-loss treatment in history. Here’s what the data says — sourced, not speculated.

• Semaglutide has been prescribed for type 2 diabetes since 2017 and for weight management since 2021 — millions of prescriptions worldwide.
• The STEP program (multiple large Phase 3 trials) consistently shows a safety profile where GI side effects are the main issue, and they’re typically mild-to-moderate (Frontiers in Endocrinology, 2022).
• The SELECT trial showed semaglutide reduced major adverse cardiovascular events by 20% in people with obesity and heart disease (NEJM, 2023).
• A 2025 Cochrane Review concluded that GLP-1 medications produce clinically meaningful weight loss, with GI adverse events as the primary concern (Cochrane, 2025).
• Serious adverse events (pancreatitis, gallbladder disease) are rare but documented. The FDA black box warning about medullary thyroid carcinoma is based on animal studies and has not been confirmed in humans.

The balanced view: No medication is risk-free. GLP-1s carry real (though mostly manageable) side effects and rare serious risks. For most people with obesity, the health risks of untreated obesity are significantly greater than the risks of GLP-1 treatment. Read our long-term effects of GLP-1 guide for the complete safety analysis.

How to Avoid GLP-1 Scams (Red Flags That Should Make You Walk Away)

As GLP-1 demand has exploded, so have sketchy providers and outright scams. The FDA has published specific warnings about unapproved products.

Red flags — if you see any of these, do not buy

• No prescription required. GLP-1 is a prescription medication. Period.
• “Research use only” or “not for human consumption” labels.
• No named prescriber. If you can’t find out who’s reviewing your health information, you’re not getting real medical care.
• No pharmacy disclosure. If they won’t tell you where your medication is made, that’s a problem.
• Prices too good to be true. If someone’s selling “semaglutide” for $50/month, ask what you’re actually getting.
• Guarantees of specific weight loss. No legitimate provider promises “lose 30 lbs in 30 days.”
• “Make GLP-1 at home” kits. Don’t. This is dangerous, unregulated, and illegal.

How to verify a provider

1. Check their website on LegitScript’s verification tool.
2. Look up the prescriber’s medical license in their state’s licensing database.
3. Ask which pharmacy fills the prescription. Look up the pharmacy’s license.
4. Check for real third-party reviews (Trustpilot, ConsumerAffairs, BBB — not just testimonials on their own site).

Our Evaluation Methodology (How We Built This Guide)

We believe you deserve to know how we formed our recommendations.

Sources we rely on

• FDA prescribing information (Wegovy, Zepbound) and FDA safety communications
• Published clinical trial data (STEP 1–5, STEP UP, SURMOUNT-1, SELECT, OASIS 4)
• Peer-reviewed journals (NEJM, JAMA, Cochrane Reviews, PMC)
• Major academic medical centers (Yale Medicine, Ohio State, Tufts, Mayo Clinic)

How we evaluate telehealth providers

We score providers on medical screening quality, pharmacy transparency, pricing clarity (including intro vs. renewal costs), cancellation policies, state availability, follow-up support quality, third-party review volume and ratings, and LegitScript certification status. We verify pricing and policies directly on provider websites and note the date of verification.

What we don’t do

• We don’t accept payment to rank providers higher.
• We don’t manufacture fake reviews or testimonials.
• We don’t make medical claims beyond what published research supports.
• We don’t imply expert review that hasn’t actually happened.

Your Next Step

You’ve done the research. You understand how GLP-1 works, what it costs, how to prepare, and what to expect. You know the side effects and how to manage them. You know the risks, the benefits, and the honest tradeoffs.

Now there’s really only one thing left to do: decide your path and start.

Frequently Asked Questions: How to Start GLP-1

References

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002. NEJM
2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205-216. NEJM
3. Novo Nordisk. STEP UP trial results. January 2025. novonordisk.com
4. Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389:2221-2232. NEJM
5. FDA. Wegovy (semaglutide injection and tablets) Prescribing Information. Revised 12/2025. FDA.gov
6. FDA. Zepbound (tirzepatide) Prescribing Information. FDA.gov
7. FDA. Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov
8. FDA. Alerts Regarding Dosing Errors with Compounded Semaglutide. FDA.gov
9. Cochrane Review. GLP-1 drugs effective for weight loss. 2025. Cochrane.org
10. Real-World Weight Loss Among Patients Initiating Semaglutide. PMC. 2024. PMC
11. Rubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325:1414-1425. JAMA
12. Wharton S, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). N Engl J Med. 2025;393:1079-1089. NEJM
13. Novo Nordisk. FDA approves Wegovy tablet. December 22, 2025. novonordisk.com
14. LegitScript Website Certification. legitscript.com
15. UCHealth. Nutrition When Taking GLP-1 Weight Loss Drugs. uchealth.org
16. Ohio State University. GLP-1 Nutrition Guidance. health.osu.edu
17. Novo Nordisk. Wegovy Savings and NovoCare Pharmacy Pricing. novocare.com
18. Eli Lilly. Zepbound Savings Options and LillyDirect Pricing. zepbound.lilly.com
19. Yale Medicine. GLP-1 Medications for Weight Loss: How to Get Started. yalemedicine.org